PBM Integration: Economists Outline Benefits Of Mergers In Senate Hearing

 
• By Grace Moser

Recent mergers between PBMs and insurers should address one long-term strategic objective of pharma – the recognition by payors of the value of biopharmaceutical products in relation to other medical costs.

Business group leadership concept as a merger and acquisition and corporate teamwork combining strengths as chess pawns forming a king crown cast shadow as a 3D illustration. - Illustration

More from Pricing Debate

More from Market Access